These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16826316)

  • 1. What is the appropriate screening protocol in Lynch syndrome?
    de Jong AE; Nagengast FM; Kleibeuker JH; van de Meeberg PC; van Wijk HJ; Cats A; Griffioen G; Vasen HF
    Fam Cancer; 2006; 5(4):373-8. PubMed ID: 16826316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome.
    Mecklin JP; Aarnio M; Läärä E; Kairaluoma MV; Pylvänäinen K; Peltomäki P; Aaltonen LA; Järvinen HJ
    Gastroenterology; 2007 Oct; 133(4):1093-8. PubMed ID: 17919485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
    Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
    Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies.
    Engel C; Vasen HF; Seppälä T; Aretz S; Bigirwamungu-Bargeman M; de Boer SY; Bucksch K; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Järvinen H; Kloor M; von Knebel Doeberitz M; Koornstra JJ; van Kouwen M; Langers AM; van de Meeberg PC; Morak M; Möslein G; Nagengast FM; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Sanduleanu S; Schackert HK; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vecht J; Verhulst ML; de Vos Tot Nederveen Cappel W; Zachariae S; Mecklin JP; Loeffler M;
    Gastroenterology; 2018 Nov; 155(5):1400-1409.e2. PubMed ID: 30063918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
    Järvinen HJ; Renkonen-Sinisalo L; Aktán-Collán K; Peltomäki P; Aaltonen LA; Mecklin JP
    J Clin Oncol; 2009 Oct; 27(28):4793-7. PubMed ID: 19720893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer.
    Engel C; Rahner N; Schulmann K; Holinski-Feder E; Goecke TO; Schackert HK; Kloor M; Steinke V; Vogelsang H; Möslein G; Görgens H; Dechant S; von Knebel Doeberitz M; Rüschoff J; Friedrichs N; Büttner R; Loeffler M; Propping P; Schmiegel W;
    Clin Gastroenterol Hepatol; 2010 Feb; 8(2):174-82. PubMed ID: 19835992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metachronous colorectal carcinoma with massive submucosal invasion detected by annual surveillance in a Lynch syndrome patient: a case report.
    Utsumi M; Tanakaya K; Mushiake Y; Kunitomo T; Yasuhara I; Taniguchi F; Arata T; Katsuda K; Aoki H; Takeuchi H
    World J Surg Oncol; 2017 Aug; 15(1):140. PubMed ID: 28764791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer surveillance in Portuguese families with lynch syndrome: a cohort study.
    Vale Rodrigues R; Claro I; Lage P; Rosa I; Ferreira S; Pereira da Silva J; Dias Pereira A
    Int J Colorectal Dis; 2018 Jun; 33(6):695-702. PubMed ID: 29523990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Outcome and Risk of Metachronous Colorectal Cancer After Surgery in Lynch Syndrome.
    Kim TJ; Kim ER; Hong SN; Kim YH; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Kim K; Kim K; Chang DK
    Ann Surg Oncol; 2017 Apr; 24(4):1085-1092. PubMed ID: 27766559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the adenoma burden in lynch syndrome.
    Kalady MF; Kravochuck SE; Heald B; Burke CA; Church JM
    Dis Colon Rectum; 2015 Apr; 58(4):388-92. PubMed ID: 25751794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutation.
    Stuckless S; Green JS; Morgenstern M; Kennedy C; Green RC; Woods MO; Fitzgerald W; Cox J; Parfrey PS
    Clin Genet; 2012 Nov; 82(5):439-45. PubMed ID: 22011075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term risk of colorectal cancer in individuals with lynch syndrome: a meta-analysis.
    Jenkins MA; Dowty JG; Ait Ouakrim D; Mathews JD; Hopper JL; Drouet Y; Lasset C; Bonadona V; Win AK
    J Clin Oncol; 2015 Feb; 33(4):326-31. PubMed ID: 25534380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonoscopy screening compliance and outcomes in patients with Lynch syndrome.
    Newton K; Green K; Lalloo F; Evans DG; Hill J
    Colorectal Dis; 2015 Jan; 17(1):38-46. PubMed ID: 25213040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry.
    Vasen HF; Velthuizen ME; Kleibeuker JH; Menko FH; Nagengast FM; Cats A; van der Meulen-de Jong AE; Breuning MH; Roukema AJ; van Leeuwen-Cornelisse I; de Vos Tot Nederveen Cappel WH; Wijnen JT
    Fam Cancer; 2016 Jul; 15(3):429-35. PubMed ID: 26973060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.
    Seppälä TT; Ahadova A; Dominguez-Valentin M; Macrae F; Evans DG; Therkildsen C; Sampson J; Scott R; Burn J; Möslein G; Bernstein I; Holinski-Feder E; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Lautrup CK; Lindblom A; Plazzer JP; Winship I; Tjandra D; Katz LH; Aretz S; Hüneburg R; Holzapfel S; Heinimann K; Valle AD; Neffa F; Gluck N; de Vos Tot Nederveen Cappel WH; Vasen H; Morak M; Steinke-Lange V; Engel C; Rahner N; Schmiegel W; Vangala D; Thomas H; Green K; Lalloo F; Crosbie EJ; Hill J; Capella G; Pineda M; Navarro M; Blanco I; Ten Broeke S; Nielsen M; Ljungmann K; Nakken S; Lindor N; Frayling I; Hovig E; Sunde L; Kloor M; Mecklin JP; Kalager M; Møller P
    Hered Cancer Clin Pract; 2019; 17():8. PubMed ID: 30858900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome.
    Hadley DW; Jenkins JF; Steinberg SM; Liewehr D; Moller S; Martin JC; Calzone KA; Soballe PW; Kirsch IR
    J Clin Oncol; 2008 Feb; 26(6):948-54. PubMed ID: 18281669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality colonoscopy and risk of interval cancer in Lynch syndrome.
    Haanstra JF; Vasen HF; Sanduleanu S; van der Wouden EJ; Koornstra JJ; Kleibeuker JH; de Vos Tot Nederveen Cappel WH
    Int J Colorectal Dis; 2013 Dec; 28(12):1643-9. PubMed ID: 23857598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpolypoid colorectal neoplasms: a challenge in endoscopic surveillance of patients with Lynch syndrome.
    Rondagh EJ; Gulikers S; Gómez-García EB; Vanlingen Y; Detisch Y; Winkens B; Vasen HF; Masclee AA; Sanduleanu S
    Endoscopy; 2013; 45(4):257-64. PubMed ID: 23440588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metachronous colorectal cancer risk in Lynch syndrome patients-should the endoscopic surveillance be more intensive?
    Anyla M; Lefevre JH; Creavin B; Colas C; Svrcek M; Lascols O; Debove C; Chafai N; Tiret E; Parc Y
    Int J Colorectal Dis; 2018 Jun; 33(6):703-708. PubMed ID: 29532206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers.
    Vasen HF; van Ballegooijen M; Buskens E; Kleibeuker JK; Taal BG; Griffioen G; Nagengast FM; Menko FH; Meera Khan P
    Cancer; 1998 May; 82(9):1632-7. PubMed ID: 9576281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.